Treatment of skin and soft tissue infections due to community-associated methicillin-resistant staphylococcus aureus in Europe: The role of trimethoprim-sulfamethoxazole

Clinical Infectious Diseases

Volumn 52, Issue 12, 2011, Pages 1471-1472

  De Angelis, Giulia ^a   Cipriani, Michela ^a   Cauda, Roberto ^a   Tacconelli, Evelina ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; FUSIDIC ACID; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; BACTERIAL STRAIN; BACTERIUM ISOLATE; EUROPE; HUMAN; LETTER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; MICROBIAL SENSITIVITY TEST; PRIORITY JOURNAL; SKIN INFECTION; SOFT TISSUE INFECTION; TYPE IV SECRETION SYSTEM;

ANTI-BACTERIAL AGENTS; COMMUNITY-ACQUIRED INFECTIONS; EUROPE; HUMANS; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; SOFT TISSUE INFECTIONS; STAPHYLOCOCCAL SKIN INFECTIONS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 79958101397     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir247     Document Type: Letter

References (8)

1. Chua K, Laurent F, Coombs G, Grayson ML, Howden BP. Not community-associated methicillin-resistant Staphylococcus aureus (CA-MRSA)! A clinician's guide to community MRSA-its evolving antimicrobial resistance and implication for therapy. Clin Infect Dis 2011; 52:99-114.
2. Goering RV, Larsen AR, Skov R, Tenover FC, Anderson KL, Dunman PM. Comparative genomic analysis of European and Middle Eastern community-associated methicillinresistant Staphylococcus aureus (CC80:ST80- IV) isolates by high-density microarray. Clin Microbiol Infect 2009; 15:748-55.
3. Stam-Bolink EM, Mithoe D, Baas WH, Arends JP, Möller AV. Spread of a methicillin- resistant Staphylococcus aureus ST80 strain in the community of the northern Netherlands. Eur J Clin Microbiol Infect Dis 2007; 26:723-7. (Pubitemid 47373410)
4. Tristan A, Bes M, Meugnier H, et al. Global distribution of Panton-Valentine leukocidin- positive methicillin-resistant Staphylococcus aureus, 2006. Emerg Infect Dis 2007; 13: 594-600. (Pubitemid 46525107)
5. Vandenesch F, Naimi T, Enright MC, et al. Community-acquired methicillin-resistant Staphylococcus aureus carrying Panton- Valentine leukocidin genes: worldwide emergence. Emerg Infect Dis 2003; 9:978-84. (Pubitemid 36944519)
6. Witte W, Braulke C, Cuny C, et al. Emergence of methicillin-resistant Staphylococcus aureus with Panton-Valentine leukocidin genes in central Europe. Eur J Clin Microbiol Infect Dis 2005; 24:1-5. (Pubitemid 40179124)
7. Nathwani D, Morgan M, Masterton RG, et al. British Society for Antimicrobial Chemotherapy Working Party on Community-onset MRSA Infections. Guidelines for UK practice for the diagnosis and management of methicillin-resistant Staphylococcus aureus (MRSA) infections presenting in the community. J Antimicrob Chemother 2008; 61:976-94. (Pubitemid 351545546)
8. Katopodis GD, Grivea IN, Tsantsaridou AJ, Pournaras S, Petinaki E, Syrogiannopoulos GA. Fusidic acid and clindamycin resistance in community-associated, methicillin-resistant Staphylococcus aureus infections in children of central Greece. BMC Infect Dis 2010; 10:351.